Melanocortin receptors as novel effectors of macrophage responses in inflammation

Frontiers in Immunology

Volumn 2, Issue SEP, 2011, Pages

  Patel, Hetal B ^a   Montero Melendez, Trinidad ^a   Greco, Karin V ^a   Perretti, Mauro ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Anti inflammatory therapeutics; G protein coupled receptor; Inflammation; Macrophage; Melanocortin receptor; Melanocortins; Melanocyte stimulating hormone; Resolution

Indexed keywords

EID: 84874090857     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2011.00041     Document Type: Short Survey

References (41)

1. Andersen, G. N., Hagglund, M., Nagaeva, O., Frangsmyr, L., Petrovska, R., Mincheva-Nilsson, L., and Wikberg, J. E. (2005). Quantitative measurement of the levels of melanocortin receptor subtype 1, 2, 3 and 5 and pro-opio-melanocortin peptide gene expression in subsets of human peripheral blood leucocytes. Scand. J. Immunol. 61, 279-284.
2. Blalock, J. E. (1985). Proopiomelanocortin-derived peptides in the immune system. Clin. Endocrinol. (Oxf.) 22, 823-827.
3. Butler, A. A., Kesterson, R. A., Khong, K., Cullen, M. J., Pelleymounter, M. A., Dekoning, J., Baetscher, M., and Cone, R. D. (2000). A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141, 3518-3521.
4. Capsoni, F., Ongari, A. M., Reali, E., and Catania, A. (2009). Melanocortin peptides inhibit urate crystalinduced activation of phagocytic cells. Arthritis Res. Ther. 11, R151.
5. Catania, A. (2007). The melanocortin system in leukocyte biology. J. Leukoc. Biol. 81, 383-392.
6. Catania, A., Lonati, C., Sordi, A., Carlin, A., Leonardi, P., and Gatti, S. (2010). The melanocortin system in control of inflammation. ScientificWorldJournal 10, 1840-1853.
7. Catania, A., Rajora, N., Capsoni, F., Minonzio, F., Star, R. A., and Lipton, J. M. (1996). The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 17, 675-679.
8. Cornish, J., Callon, K. E., Mountjoy, K. G., Bava, U., Lin, J. M., Myers, D. E., Naot, D., and Reid, I. R. (2003). alpha -Melanocyte-stimulating hormone is a novel regulator of bone. Am. J. Physiol. Endocrinol. Metab. 284, E1181-E1190.
9. Delgado, R., Carlin, A., Airaghi, L., Demitri, M. T., Meda, L., Galimberti, D., Baron, P., Lipton, J. M., and Catania, A. (1998). Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J. Leukoc. Biol. 63, 740-745.
10. Gantz, I., and Fong, T. M. (2003). The melanocortin system. Am. J. Physiol. Endocrinol. Metab. 284, E468-E474.
11. Getting, S. J., Christian, H. C., Flower, R. J.,and Perretti,M. (2002). Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis Rheum. 46, 2765-2775.
12. Getting, S. J., Christian, H. C., Lam, C. W., Gavins, F. N., Flower, R. J., Schioth, H. B., and Perretti, M. (2003). Redundancy of a functional melanocortin 1 receptor in the anti-inflammatory actions of melanocortin peptides: studies in the recessive yellow (e/e) mouse suggest an important role for melanocortin 3 receptor. J. Immunol. 170, 3323-3330.
13. Getting, S. J., Flower, R. J., and Perretti, M. (1999a). Agonism at melanocortin receptor type 3 on macrophages inhibits neutrophil influx. Inflamm. Res. 48(Suppl. 2), S140-S141.
14. Getting, S. J., Gibbs, L., Clark, A. J., Flower, R. J., and Perretti, M. (1999b). POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation. J. Immunol. 162, 7446-7453.
15. Getting, S. J., Lam, C. W., Leoni, G., Gavins, F. N., Grieco, P., and Perretti, M. (2006). [D-Trp8]-gammamelanocyte-stimulating hormone exhibits anti-inflammatory efficacy in mice bearing a nonfunctional MC1R (recessive yellow e/e mouse). Mol. Pharmacol. 70, 1850-1855.
16. Getting, S. J., Riffo-Vasquez, Y., Pitchford, S., Kaneva, M., Grieco, P., Page, C. P., Perretti, M., and Spina, D. (2008). A role for MC3R in modulating lung inflammation. Pulm. Pharmacol. Ther. 21, 866-873.
17. Gordon, S. (2003). Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
18. Gutman, A. B., and Yu, T. F. (1950). Effects of adrenocorticotropic hormone (ACTH) in gout. Am. J. Med. 9, 24-30.
19. Hench, P. S., Kendall, E. C., Slocumb, C. H., and Polley, H. F. (1949). Theeffectofahormoneof the adrenal cortex (17-hydroxy-11dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Mayo Clin. Proc. 24, 181-197.
20. Joseph, C. G., Yao, H., Scott, J. W., Sorensen, N. B., Marnane, R. N., Mountjoy, K. G., and Haskell-Luevano, C. (2010). gamma-Melanocyte stimulation hormone (gamma-MSH) truncation studies results in the cautionary note that gamma-MSH is not selective for the mouse MC3R over the mouse MC5R. Peptides 31, 2304-2313.
21. Kang, L., McIntyre, K. W., Gillooly, K. M., Yang, Y., Haycock, J., Roberts, S., Khanna, A., Herpin, T. F., Yu, G., Wu, X., Morton, G. C., Tuerdi, H., Koplowitz, B., Walker, S. G., Wardwell-Swanson, J., Macor, J. E., Lawrence, R. M., and Carlson, K. E. (2006). A selective small molecule agonist of the melanocortin-1 receptor inhibits lipopolysaccharide-induced cytokine accumulation and leukocyte infiltration in mice. J. Leukoc. Biol. 80, 897-904.
22. Kubes, P., and Granger, D. N. (1996). Leukocyte-endothelial cell interactions evoked by mast cells. Cardiovasc. Res. 32, 699-708.
23. Lacey, D. L., Timms, E., Tan, H. L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, Y. X., Kaufman, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J., and Boyle, W. J. (1998). Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176.
24. Lam, C. W., Getting, S. J., and Perretti, M. (2005). In vitro and in vivo induction of heme oxygenase 1 in mouse macrophages following melanocortin receptor activation. J. Immunol. 174, 2297-304.
25. Lam, C. W., Perretti, M., and Getting, S. J. (2006). Melanocortin receptor signaling in RAW264.7 macrophage cell line. Peptides 27, 404-412.
26. Leoni, G., Patel, H. B., Sampaio, A. L., Gavins, F. N., Murray, J. F., Grieco, P., Getting, S. J., and Perretti, M. (2008). Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion. FASEB J. 22, 4228-4238.
27. Leoni, G., Voisin, M. B., Carlson, K., Getting, S., Nourshargh, S., and Perretti, M. (2010). The melanocortin MC(1) receptor agonist BMS470539 inhibits leucocyte trafficking in the inflamed vasculature. Br. J. Pharmacol. 160, 171-180.
28. Li, D., and Taylor, A. W. (2008). Diminishment of alpha-MSH anti-inflammatory activity in MC1r siRNA-transfected RAW264.7 macrophages. J. Leukoc. Biol. 84, 191-198.
29. Lipton, J. M., and Catania, A. (1997). Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH. Immunol. Today 18, 140-145.
30. Luger, T. A., Scholzen, T. E., Brzoska, T., and Bohm, M. (2003). New insights into the functions of alpha-MSH and related peptides in the immune system. Ann. N. Y. Acad. Sci. 994, 133-140.
31. Mandrika, I., Muceniece, R., and Wikberg, J. E. (2001). Effects of melanocortin peptides in lipopolysaccharide/interferongamma-induced NF-kappaB DNA binding and nitric oxide production in macrophage-like RAW 264.7 cells: evidence for dual mechanisms of action. Biochem. Pharmacol. 61, 613-621.
32. Manna, S. K., and Aggarwal, B. B. (1998). Alpha-melanocytestimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J. Immunol. 161, 2873-2880.
33. Montero-Melendez, T., Patel, H. B., Seed, M., Nielsen, S., Jonassen, T. E. N., and Perretti, M. (2011). The melanocortin agonist AP214 exerts anti-inflammatory and pro-resolving properties: evidence for a major involvement of the melanocortin receptor type 3. Am. J. Pathol. 179, 259-269.
34. Mountjoy, K. G. (2010). Functions for pro-opiomelanocortin-derived peptides in obesity and diabetes. Biochem. J. 428, 305-324.
35. Patel, H. B., Bombardieri, M., Sampaio, A. L., D'Acquisto, F., Gray, M., Grieco, P., Getting, S. J., Pitzalis, C., and Perretti, M. (2010a). Anti-inflammatory and antiosteoclastogenesis properties of endogenous melanocortin receptor type 3 in experimental arthritis. FASEB J. 24, 4835-4843.
36. Patel, H. B., Leoni, G., Melendez, T. M., Sampaio, A. L., and Perretti, M. (2010b). Melanocortin control of cell trafficking in vascular inflammation. Adv. Exp. Med. Biol. 681, 88-106.
37. Schwab, J. M., Chiang, N., Arita, M., and Serhan, C. N. (2007). Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447, 869-874.
38. Star, R. A., Rajora, N., Huang, J., Stock, R. C., Catania, A., and Lipton, J. M. (1995). Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc. Natl. Acad. Sci. U.S.A. 92, 8016-8020.
39. Taherzadeh, S., Sharma, S., Chhajlani, V., Gantz, I., Rajora, N., Demitri, M. T., Kelly, L., Zhao, H., Ichiyama, T., Catania,A., and Lipton, J. M. (1999). alpha-MSH and its receptors in regulation of tumor necrosis factoralpha production by human monocyte/macrophages. Am. J. Physiol. 276(Pt 2), R1289-R1294.
40. Tailor,A.,Tomlinson,A.,Salas,A.,Panes, J., Granger, D. N., Flower, R. J., and Perretti, M. (1999). Dexamethasone inhibition of leucocyte adhesion to rat mesenteric postcapillary venules: role of intercellular adhesion molecule 1 and KC. Gut 45, 705-712.
41. Wikberg, J. E., Muceniece, R., Mandrika,I.,Prusis,P.,Lindblom,J.,Post, C., and Skottner, A. (2000). New aspects on the melanocortins and their receptors. Pharmacol. Res. 42, 393-420.